Dr Anton Uvarov has significant experience as an equity analyst, both domestically and internationally, and is particularly interested in early-stage startups.
Prior to his move to Australia, Dr Uvarov was senior associate at Citigroup Global Markets where he spent two years as a member of New York based healthcare team.
Dr Uvarov has a PhD from University of Manitoba, Canada and an MBA from University of Calgary, Canada.